These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

82 related articles for article (PubMed ID: 7783312)

  • 21. [Clinical efficacy of tosufloxacin in children with pneumonia due to Mycoplasma pneumoniae].
    Sakata H
    Jpn J Antibiot; 2012 Jun; 65(3):173-9. PubMed ID: 23173293
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Therapeutic prospects of new fluoroquinolones].
    Bryskier A; Chantot JF; Veyssier P
    Presse Med; 1985 Dec; 14(45):2291-4. PubMed ID: 2935814
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [A new way to fight surgical infections. High activity of trovafloxacin, even against anaerobic bacteria].
    Chirurg; 1998 Jun; 69(6 Suppl):1-4. PubMed ID: 9696895
    [No Abstract]   [Full Text] [Related]  

  • 24. Nigerian judge orders arrests of Pfizer officials.
    Lenzer J
    BMJ; 2008 Jan; 336(7634):11. PubMed ID: 18174580
    [No Abstract]   [Full Text] [Related]  

  • 25. Trovofloxacin for the treatment of chronic granuloma inguinale.
    Hsu SL; Chia JK
    Sex Transm Infect; 2001 Apr; 77(2):137. PubMed ID: 11287695
    [No Abstract]   [Full Text] [Related]  

  • 26. Nigerian government investigates Pfizer drug trial allegations.
    Ahmad K
    Lancet; 2001 Jan; 357(9250):129. PubMed ID: 11197410
    [No Abstract]   [Full Text] [Related]  

  • 27. Protection against lipopolysaccharide-induced death by fluoroquinolones.
    Khan AA; Slifer TR; Araujo FG; Suzuki Y; Remington JS
    Antimicrob Agents Chemother; 2000 Nov; 44(11):3169-73. PubMed ID: 11036044
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Drug company sued over research trial in Nigeria.
    Ahmad K
    Lancet; 2001 Sep; 358(9284):815. PubMed ID: 11564494
    [No Abstract]   [Full Text] [Related]  

  • 29. Appeals court rules that Nigerian families can sue Pfizer in US.
    Lenzer J
    BMJ; 2009 Feb; 338():b458. PubMed ID: 19201810
    [No Abstract]   [Full Text] [Related]  

  • 30. [Evaluation of proposed criteria of disk susceptibility testing for tosufloxacin and lomefloxacin in NCCLS guidelines and WHO standards].
    Aihara M; Oguri T; Kanno H; Kubo S; Honda M; Satoh K; Daimon Y; Yamanaka K; Sugawara K; Furuta T
    Rinsho Byori; 1992 Jan; 40(1):73-80. PubMed ID: 1312183
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The new fluoroquinolones: a review.
    Dabbs DJ; Limb DI; Spencer RC
    Med Lab Sci; 1987 Jan; 44(1):59-65. PubMed ID: 3309533
    [No Abstract]   [Full Text] [Related]  

  • 32. Proper use versus abuse of trovafloxacin.
    Fulghum MP; Grimaldi D; Schoelles-Williams J
    Am J Health Syst Pharm; 2000 Jan; 57(1):76, 78. PubMed ID: 10630563
    [No Abstract]   [Full Text] [Related]  

  • 33. Common questions about the newer fluoroquinolone antibiotics.
    North DS
    Nurse Pract; 1999 Mar; 24(3):124-7. PubMed ID: 10100244
    [No Abstract]   [Full Text] [Related]  

  • 34. Antimicrobial agents for the prevention and treatment of abdominal infections: a new generation?
    Rotstein OD
    Am J Surg; 1998 Dec; 176(6A Suppl):80S-83S. PubMed ID: 9935262
    [No Abstract]   [Full Text] [Related]  

  • 35. Trovafloxacin-associated exfoliative dermatitis in a homecare patient.
    Triller DM; Miller MT; Briceland LL; Gordon FS
    Ann Pharmacother; 1999 Oct; 33(10):1122. PubMed ID: 10534226
    [No Abstract]   [Full Text] [Related]  

  • 36. Clinical pharmacologic features of fluoroquinolone antimicrobial drugs.
    Neer TM
    J Am Vet Med Assoc; 1988 Sep; 193(5):577-80. PubMed ID: 2844709
    [No Abstract]   [Full Text] [Related]  

  • 37. Antimicrobial therapy for surgical prophylaxis and for intra-abdominal and gynecologic infections.
    Weigelt JA; Faro S
    Am J Surg; 1998 Dec; 176(6A Suppl):1S-3S. PubMed ID: 9935248
    [No Abstract]   [Full Text] [Related]  

  • 38. [Clinical studies on tosufloxacin (TFLX) in urology].
    Fukushima S; Moriyama M; Miyamoto H; Hosaka M; Kubota Y; Kinoshita Y; Noguchi K; Shuin T; Noguchi S; Yoshimura S
    Hinyokika Kiyo; 1992 Apr; 38(4):501-6. PubMed ID: 1529827
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Effect of new oral antimicrobial agents in outpatient treatment of pneumonia in children].
    Ouchi K; Sunakawa K
    Jpn J Antibiot; 2014 Jun; 67(3):157-66. PubMed ID: 25163249
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [In vitro effect of new fluoroquinolones and betalactamines combinations against enterococci].
    Aubert G; Pozzetto B; Dorche G
    Pathol Biol (Paris); 1991 Dec; 39(10):1006-8. PubMed ID: 1666668
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.